Abstract
Ethyl (3aR,7R,7aR)-2,2-dimethyl-7-((methylsulfonyl)oxy)-3a,6,7,7a-tetrahydrobenzo [d][1,3]dioxole-5-carboxylate is a key intermediate of oseltamivir, and its crystal structure and density functional theory (DFT) studies are conducive to exploring more reaction pathways for industrial applications. In this paper, the title compound was synthesized by esterification, condensation and sulfonylation from shikimic acid as the starting material. Its single crystal was obtained by solution crystallization and crystallographic analysis. The optimal structure and frontier orbital energies were calculated using the DFT in the B3LYP/6-311+G(2d, p) mode. The molecular structure optimized by DFT was compared with the crystal structure determined by X-ray single crystal diffraction, which provided similar results. The electrostatic formula and the frontier molecular orbitals of the molecule were further studied by using the DFT to reveal the physicochemical properties of the investigated compound.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.